Plasma Proteomics for Differential Diagnosis & Molecular Staging of Neurodegenerative Diseases
9:30 am - Tuesday 1st December 2026
- Explore plasma protein signatures across Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia using data from international cohorts
- Discuss how GFAP changes across the Alzheimer’s disease continuum and how lower plasma levels of integrins αV and αM were also observed in autopsy-confirmed Lewy body disease
- Show how these findings informed the development of a 21-protein plasma panel, which was validated in an independent multicentre cohort